Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gracell Biotechnologies Announces Pricing of Initial Public Offering 2021-01-08 14:55
Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho 2021-01-08 14:00
deCODE genetics: Monozygous but not identical 2021-01-08 00:00
Inteleos and APA Partner to Offer Free Mental Health Resources to All Healthcare Professionals 2021-01-07 22:02
Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics 2021-01-07 21:20
Dr David Stamler Appointed CEO 2021-01-07 21:00
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies 2021-01-07 20:31
CORI Innolab Launches CORI Super Recharge 96(TM): Rechargeable Super Mask on Kickstarter 2021-01-07 20:00
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain 2021-01-07 20:00
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China 2021-01-07 18:45
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics 2021-01-07 17:00
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange 2021-01-07 16:13
Bioworkshops successfully passed EU QP audit 2021-01-06 22:00
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer 2021-01-06 21:54
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer 2021-01-06 21:52
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding 2021-01-06 21:25
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18 2021-01-06 21:00
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease 2021-01-06 20:24
Eleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member 2021-01-06 17:00
Yiling Pharma expects to double its YoY net profit in 2020 2021-01-06 16:55
1 637 638 639 640 641 1097